How China is Rewriting the Rules of AI Healthcare with Dr. Ruby Wang

China’s biotech and healthcare sectors are evolving at extraordinary speed — from AI-powered “doctor avatars” and digital health super apps to a wave of Chinese drug innovation reshaping the global pharmaceutical industry.

In this episode, I speak with physician and healthcare strategist Dr. Ruby Wang about the latest trends in China's AI + healthcare innovation.We discuss:

• Why Western pharma companies are rushing to license Chinese drugs
• China’s rise as a global biotech powerhouse
• AI doctors, digital hospitals, and health super apps
• The role of Alibaba, Ant Group, and DeepSeek in healthcare
• Why China’s healthcare digitization is moving faster than the West
• The future of AI in medicine and diagnosticsChinese medical devices, robotics, and healthcare hardware
• How Chinese regulators accelerated biotech innovation
• Whether healthcare can become China’s next major global export industry
• The challenges China still faces in healthcare access and inequality

Ruby Wang is a UK-trained physician, founder of China Health Pulse, and author of the upcoming book China Cure, which explores the global impact of China’s biotech and AI healthcare advances.

Links:

China Health Pulse newsletter and podcast: https://www.chinahealthpulse.com/

For transcripts and more, check out the ⁠High Capacity newsletter⁠: https://www.highcapacity.org/

More about the host, Kyle Chan: https://www.kyleichan.com/